Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 Pandemic
Authors:
- 1 February 2024
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 178 (2) , 195-197
Abstract
This cohort study evaluates respiratory syncytial virus (RSV)–related hospitalizations and disease severity from 2012 to 2023 in children younger than 5 years.Keywords
This publication has 5 references indexed in Scilit:
- Shifting Epidemiology and Severity of Respiratory Syncytial Virus in Children During the COVID-19 PandemicJAMA Pediatrics, 2023
- Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infantsNature Medicine, 2023
- Seasonality of Respiratory Syncytial Virus — United States, 2017–2023MMWR. Morbidity and Mortality Weekly Report, 2023
- Viral Lineages in the 2022 RSV Surge in the United StatesNew England Journal of Medicine, 2023
- Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide cohort studyThe Lancet Child & Adolescent Health, 2023